- Home
- ARL vs VOR Comparison
ARL vs VOR Comparison
Compare ARL & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARL
- VOR
- Stock Information
- Founded
- ARL 1999
- VOR 2015
- Country
- ARL United States
- VOR United States
- Employees
- ARL N/A
- VOR N/A
- Industry
- ARL Building operators
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- ARL Real Estate
- VOR Health Care
- Exchange
- ARL Nasdaq
- VOR Nasdaq
- Market Cap
- ARL 245.7M
- VOR 207.1M
- IPO Year
- ARL N/A
- VOR 2021
- Fundamental
- Price
- ARL $16.01
- VOR $20.56
- Analyst Decision
- ARL
- VOR Buy
- Analyst Count
- ARL 0
- VOR 6
- Target Price
- ARL N/A
- VOR $84.00
- AVG Volume (30 Days)
- ARL 1.1K
- VOR 411.3K
- Earning Date
- ARL 11-07-2025
- VOR 11-07-2025
- Dividend Yield
- ARL N/A
- VOR N/A
- EPS Growth
- ARL N/A
- VOR N/A
- EPS
- ARL N/A
- VOR N/A
- Revenue
- ARL $48,139,000.00
- VOR N/A
- Revenue This Year
- ARL N/A
- VOR N/A
- Revenue Next Year
- ARL N/A
- VOR N/A
- P/E Ratio
- ARL N/A
- VOR N/A
- Revenue Growth
- ARL N/A
- VOR N/A
- 52 Week Low
- ARL $9.43
- VOR $2.62
- 52 Week High
- ARL $18.00
- VOR $65.80
- Technical
- Relative Strength Index (RSI)
- ARL 53.74
- VOR 34.33
- Support Level
- ARL $15.61
- VOR $23.12
- Resistance Level
- ARL $16.89
- VOR $26.76
- Average True Range (ATR)
- ARL 0.24
- VOR 2.14
- MACD
- ARL 0.02
- VOR -1.40
- Stochastic Oscillator
- ARL 51.64
- VOR 8.04
About ARL American Realty Investors Inc.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.